Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors

Details for Australian Patent Application No. 2009242145 (hide)

Owner Novartis AG

Inventors Leblanc, Catherine; Shaw, Duncan; Ritchie, Cathy; Stiefl, Nikolaus Johannes

Agent Davies Collison Cave

Pub. Number AU-B-2009242145

PCT Pub. Number WO2009/133070

Priority 08155405.7 29.04.08 EP

Filing date 27 April 2009

Wipo publication date 5 November 2009

Acceptance publication date 5 July 2012

International Classifications

C07D 403/10 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/437

C07D 405/10 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

25 November 2010 PCT application entered the National Phase

  PCT publication WO2009/133070 Priority application(s): WO2009/133070

5 July 2012 Application Accepted

  Published as AU-B-2009242145

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009242175-Ordered mesoporous silica material

2009242144-Diffuser for shaving foam spray